Concepedia

Publication | Closed Access

Results of the randomized, placebo-controlled phase I/IIB trial of CV9104, an mRNA based cancer immunotherapy, in patients with metastatic castration-resistant prostate cancer (mCRPC)

DOI

68

Citations

0

References

2017

Year

Arnulf Stenzl, S. Feyerabend, Isabel Syndikus, Tomasz Sarosiek, Hubert Kübler, Axel Heidenreich, Richard Cathomas, Carsten Grüllich, Yohann Loriot, S.L. Perez Gracia,
Annals of Oncology

No additional data available for this publication yet. Check back later!